Manufacturer Intelligence · Based on 98,561 FDA 510(k) records · 75 countries

FDA 510(k) Medical Device Manufacturers - France

Name: FDA 510(k) Medical Device Manufacturers
Creator: 510k Database

French medical device manufacturers ranked by FDA 510(k) submission volume. This is not a curated directory - rankings reflect real submission activity extracted from FDA accessdata.gov records.

Compare manufacturers by FDA 510(k) submission activity
Identify clearance rates, active panels and years of FDA activity
Filter by country or FDA review panel specialty

174

Manufacturers

France

Country

France FDA 510(k) Overview

174

Manufacturers

590

Submissions

99%

Clearance rate

Leading France FDA 510(k) manufacturers include Bio-Rad Laboratories, GE Medical Systems SCS, Newclip Technics and 171 others.

French medical device manufacturers have submitted 590 FDA 510(k) notifications since 1990, with a 99.2% clearance rate across 174 manufacturers. France's medtech sector shows consistent FDA activity in cardiovascular, orthopedic and ophthalmic devices, supported by a strong regulatory affairs infrastructure for international market access.

Active in FDA 510(k) submissions since 1990. Many France manufacturers work with FDA regulatory consultants to support U.S. market entry.

FDA 510(k) France Manufacturers

1–50 of 174

#	Manufacturer	Submissions	Cleared	Active panels	Country
1	Bio-Rad Laboratories Hauts-De-Seine	46	98%	CH HE IM +1	FR
2	GE Medical Systems SCS Buc Cedex	38	100%	RA	FR
3	Newclip Technics Haute-Goulaine	34	100%	OR	FR
4	Quantel Medical Cournon D'Auvergne-Cedex	30	100%	OP RA SU	FR
5	Sopro Marseille	25	100%	DE GU OB +3	FR
6	Medicrea International SA Neyron	25	100%	OR	FR
7	Satelec Merignac	24	100%	DE NE OR +1	FR
8	S.M.A.I.O Saint-Priest	10	100%	OR RA	FR
9	Biomerieux S.A. Craponne	9	100%	MI	FR
10	FH Industrie Quimper Finistere	9	100%	OR RA	FR
11	HORIBA ABX SAS Montpellier Cedex 4	8	100%	CH HE IM	FR
12	Supersonic Imagine Aix-En-Provence Cedex	7	100%	RA	FR
13	Avicenna.Ai La Ciotat	7	100%	RA	FR
14	Mauna Kea Technologies Paris	6	100%	NE SU	FR
15	Biosphere Medical, S.A. Roissy-En-France	6	100%	CV NE	FR
16	Clariance, Sas Beaurains	6	100%	OR	FR
17	Sim&Cure Grabels	6	100%	CV NE	FR
18	Therapixel Valbonne	6	100%	RA	FR
19	Pixee Medical Besan?on	6	100%	OR RA	FR
20	Ecential Robotics Gieres	6	100%	OR RA	FR
21	Medtech S.A Montpellier	5	100%	NE OR	FR
22	Blue Ortho La Tronche	5	100%	OR	FR
23	Spinevision, S.A.S. Antony	5	100%	OR	FR
24	Volta Medical Marseille	5	100%	CV	FR
25	Sonio Paris	5	100%	RA	FR
26	Brightheart Paris	5	100%	RA	FR
27	Anthogyr Sallanches	4	100%	DE HO	FR
28	Trophy Marne La Vallee Cedex 2	4	100%	DE RA	FR
29	Fci (France Chirurgie Instrumentation) Sas Paris	4	100%	OP	FR
30	Moon Surgical Paris	4	100%	SU	FR
31	Sophysa Orsay	4	100%	NE	FR
32	Biocorp Production Issoire	4	100%	HO	FR
33	Therapanacea Sas Paris	4	100%	RA	FR
34	Medicrea International S.A.S. (Medtronic) Rillieux-La-Pape	4	100%	OR RA	FR
35	3-D Matrix Europe SAS Caluire Et Cuire	4	100%	GU SU	FR
36	Implanet Allee Francois Magendie	3	100%	OR	FR
37	Cousin Biotech Sas Wervicq-Sud	3	100%	OR	FR
38	Hemodia Sas Labege	3	100%	OR	FR
39	Novastep Saint Gregoire	3	100%	OR	FR
40	Phakos Montreuil	3	100%	OP	FR
41	Idmed Marseille	3	100%	AN	FR
42	Bioserenity Sas Paris	3	100%	CV NE	FR
43	Dosisoft Cachan	3	100%	RA	FR
44	Biom?rieux SA Marcy-L'?toile	3	100%	CH MI	FR
45	Therapanacea Paris	3	100%	RA	FR
46	Biotech Dental, Sas Salon De Provence	3	100%	DE HO	FR
47	Institut Georges Lopez Lissieu	3	100%	GU	FR
48	Stephanix La Ricamarie	3	100%	RA	FR
49	E-Scopics Aix-En-Provence	3	100%	RA	FR
50	Olea Medical S.A.S. La Ciotat	3	100%	RA	FR

About This FDA 510(k) Manufacturer Database

Data Source and Methodology

Rankings are based on the total number of published FDA 510(k) submissions per manufacturer in the 510k Database dataset, derived from FDA 510(k) public files. This is not a curated or paid listing - manufacturer rankings reflect real regulatory activity.

Used by regulatory affairs teams and medtech consultants to benchmark manufacturer activity, identify predicate device candidates, and analyze competitive positioning across FDA review panels.